LAEKNA INC
(HKEX: 2105)
Laekna, Inc. engages in the provision of clinical stage research and development of biopharmaceutical products. It primarily focuses on cancer and liver fibrosis. The company was founded by Xiang Yang Lu on July 29, 2016 and is headquartered in Shanghai, China.
14.800 -
+0.330
(+2.28%)
Range
14.040 - 15.000
(6.84%)
Open
14.600
Previous Close
14.470
Bid Price
14.790
Bid Volume
('000)
1
Ask Price
14.800
Ask Volume
('000)
1
Volume
('000)
1,529
Value
22,409,205
Remark
-
Delayed prices. Updated at 29 Jan 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
